Published in Cancer Weekly, March 3rd, 1997
The ACR said that a U.S. National Institutes of Heath (NIH) panel failed to recognize and incorporate into its report important follow-up data from clinical trials that confirm the benefits of this test. The College also said that the panel's decision not to recommend screening mammography for women in their 40s was regrettable and not in the best interest of American women in this age group.
Two independent studies from Sweden, one from Gothenburg, the other from Malmo, reported at the meeting a statistically significant decrease in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.